Medical/Pharmaceuticals
Experts Underscore Essential Role for Patient Blood Management in and beyond the COVID-19 Pandemic
* Blood services and health authorities warn that a decline in donations due to COVID-19 could result in blood shortages, forcing frontline health care providers to face further difficult clinical decisions;[1],[2] * An international group of 43 medical experts points at a win-win concept to ...
2020-05-14 14:00
2808
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)
FORT LAUDERDALE, Florida, May 14, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in partnership ...
2020-05-14 09:26
3340
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, May 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today jointl...
2020-05-14 07:30
9059
Hanwha Helps the Fight Against COVID-19 by Providing Life Park, a Smart Training Institute in the City of Yongin, Gyeonggi Province in Korea, as a Treatment Center
SEOUL, South Korea, May 14, 2020 /PRNewswire/ -- Hanwha is closely monitoring
the COVID-19 global health crisis and implementing various measures to protect
the health and safety of their employees and slow the spread of coronavirus by
helping hard-hit communities.
2020-05-14 07:00
2540
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
- Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib†, the first MET inhibitor to have received a regulatory approval for NSCLC withMET gene alterations - Two-year follow-up for first-in-class bifunctional im...
2020-05-14 06:46
2524
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
HYDERABAD, India, May 14, 2020 /PRNewswire/ -- Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distributio...
2020-05-14 01:56
3490
Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan
Demand for telehealth will soar by 64.3% in the US in 2020 as the COVID-19 pandemic disrupts the practice of medicine and the delivery of healthcare SANTA CLARA, California, May 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Telehealth—A Technology-Based Weapon in the War Against the...
2020-05-14 01:05
2950
DERMALOG Fever Detection Protects Draegerwerk AG Production
- Despite Covid-19, assembly lines in many factories do not stop. Production at Draeger is also in full operation. As a manufacturer of ventilators, the German company's products are currently in high demand. To keep the risk of infection among employees as low as possible, Draeaeger has implemen...
2020-05-13 21:10
1602
Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19
IRVINE, California, May 13, 2020 /PRNewswire/ -- Irvine, California-based
Fluxergy LLC, a diagnostic test company, is making a$30 million investment to
expand its capability to scale production of the Fluxergy Analyzer diagnostic
testing system in response to the COVID-19 pandemic.
2020-05-13 18:41
3252
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
HANGZHOU, China and SHAOXING, China, May 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from China's National Medical Products Administration (NMPA) for its in-house developed Category 1 Drug ASC41 to conduct clinical trials for Non-al...
2020-05-13 18:30
3057
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months
* CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for dual IND filing inChina and the US * Completion of the project demonstrates the significant speed to clinic achievable with CMAB's fully integrated development and manufacturing platform * QureBio'...
2020-05-13 18:29
2635
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
MUMBAI, India, May 13, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (and hereafter referred to as "Cipla") today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine R...
2020-05-13 17:51
3447
Big Start helps businesses secure PPE gear as global demand spikes
PERTH, Australia, May 13, 2020 /PRNewswire/ -- Australian medical supply
innovator Big Start is being inundated with orders from around the world as
companies seek to protect staff as lockdowns are lifted and businesses get back
to work.
Big Start's
2020-05-13 14:00
1981
Low-dose radiographs could reveal typical lung changes
MUNICH, May 13, 2020 /PRNewswire/ -- Researchers at the Technical University of Munich (TUM) have developed an innovative x-ray method for lung diagnostics, which they now plan to test in one of its first applications for diagnosis of the respiratory ailmentCOVID-19 caused by Coronavirus. The met...
2020-05-13 08:20
2470
COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark
RARITAN, New Jersey, May 12, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its COVID-19 total antibody test received CE Mark. The test offers excellent perf...
2020-05-12 20:00
1867
QPS Announces Novel Coronavirus/COVID-19 Testing Capability
NEWARK, Delaware, May 12, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, announces a newly developed capability to conduct COVID-19 testing, available as ofMonday, May 11, 2020. QP...
2020-05-12 19:11
2807
Yili Group Donates Over 170,000 Face Masks to Thailand in Coronavirus Fight
BANGKOK, May 12, 2020 /PRNewswire/ -- Asia dairy giant Yili Group cooperates with its Thai subsidiary Chomthana and Thailand Siam Dragon Association to deliver 170,400 face masks and other anti-epidemic supplies to the Thai Ministry of Public Health,Royal Thai Police and Phuket Police Headquar...
2020-05-12 18:09
4164
Invivoscribe Submits LeukoStrat® CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners
SAN DIEGO, May 12, 2020 /PRNewswire/ -- Invivoscribe is pleased to announce that theirLeukoStrat® CDx FLT3 Mutation Assay was submitted to regulatory authorities inChina in April in support of the Astellas New Drug Application (NDA) submission of XOSPATA® (gilteritinib) for treatment of adult pat...
2020-05-12 18:00
2920
Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations
VISTA, California, May 12, 2020 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 se...
2020-05-12 11:19
3384
Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations
VISTA, California, May 12, 2020 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 se...
2020-05-12 10:00
2178
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
